A new study being published by the British Journal of Pharmacology, and published ahead of print this month by the National Institute of Health, has found that cannabidiol, a compound found naturally in cannabis, may be a safe and effective treatment for chemotherapy-induced neuropathic pain (CIPN). This discovery is a medical breakthrough, given that, according to the study’s researchers; “to date no one drug or drug class is considered to be effective for reversal of CIPN”.
For the study cannabidiol was used on mice (with breast cancer) going through chemotherapy. Researchers found that; “CBD (cannabidiol) is protective against PAC [Paclitaxel, a chemotherapy drug] induced neurotoxicity… Furthermore, CBD treatment was devoid of other nervous system effects such as conditioned reward or cognitive impairment.” They continue; “CBD also did not attenuate the efficacy of PAC in inhibiting breast cancer cell viability.”
They conclude that; “Taken together, adjunct treatment with CBD during PAC chemotherapy treatment may be safe and effective in the prevention or attenuation of CIPN.”
The study can be found by clicking here.